specialty pharmaceuticals

BOLOGNA AND MILAN, Italy, August 13, 2026 Alfasigma S.p.A. has entered into a share purchase agreement with SEVER Life...

DUBLIN, Ireland, July 8, 2026 Keenova Therapeutics plc has announced positive Phase 3 clinical trial results for XIAFLEX® (collagenase...

Toronto, Ontario & Chicago, Illinois — November 20, 2025 — Medexus Pharmaceuticals Inc. has announced that the Toronto Stock...